Joel Ross

780 total citations
20 papers, 235 citations indexed

About

Joel Ross is a scholar working on Physiology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Joel Ross has authored 20 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 5 papers in Pharmacology and 5 papers in Psychiatry and Mental health. Recurrent topics in Joel Ross's work include Alzheimer's disease research and treatments (9 papers), Dementia and Cognitive Impairment Research (5 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Joel Ross is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Dementia and Cognitive Impairment Research (5 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Joel Ross collaborates with scholars based in United States, Italy and United Kingdom. Joel Ross's co-authors include L. Ashley Cowart, Sarah Russo, Wolfgang H. Oertel, Karla Eggert, Georg Adler, Joshua R. Shua‐Haim, Iman H. Hasan, K. D. Rainsford, John A. Talbott and Daniel N. Stern and has published in prestigious journals such as Neurology, Journal of Alzheimer s Disease and Alzheimer s & Dementia.

In The Last Decade

Joel Ross

20 papers receiving 222 citations

Peers

Joel Ross
Shajan Koshy Malaysia
Gül Özbey Türkiye
William H. Cevallos United States
Viviana Noriega Chile
Aikaterini Zisaki Greece
Nina Gårevik Sweden
Ashley Selman United States
Renmin Yang China
Paola Bisceglia Italy
Özgür Gündüz Türkiye
Shajan Koshy Malaysia
Joel Ross
Citations per year, relative to Joel Ross Joel Ross (= 1×) peers Shajan Koshy

Countries citing papers authored by Joel Ross

Since Specialization
Citations

This map shows the geographic impact of Joel Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Ross more than expected).

Fields of papers citing papers by Joel Ross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Ross. The network helps show where Joel Ross may publish in the future.

Co-authorship network of co-authors of Joel Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Ross. A scholar is included among the top collaborators of Joel Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Ross. Joel Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasan, Iman H., K. D. Rainsford, & Joel Ross. (2023). Salsalate: a pleotropic anti-inflammatory drug in the treatment of diabetes, obesity, and metabolic diseases. Inflammopharmacology. 31(6). 2781–2797. 12 indexed citations
2.
Burdea, Grigore, et al.. (2016). A serious gaming alternative to pen-and-paper cognitive scoring: A pilot study of BrightScreener™. 9(3). 255–264. 3 indexed citations
3.
Russo, Sarah, Joel Ross, & L. Ashley Cowart. (2013). Sphingolipids in Obesity, Type 2 Diabetes, and Metabolic Disease. Handbook of experimental pharmacology. 373–401. 89 indexed citations
4.
Ross, Joel, Abhijit Chatterjee, Jaron L. Winston, et al.. (2013). O3–06–05: Sustained cognitive benefit in patients with mild cognitive impairment (MCI) upon prolonged treatment with CHF5074. Alzheimer s & Dementia. 9(4S_Part_13). 3 indexed citations
5.
Coric, Vlad, Stephen Salloway, Christopher van Dyck, et al.. (2013). P1–343: A phase II study of the gamma‐secretase inhibitor avagacestat (BMS‐708163) in predementia Alzheimer's disease. Alzheimer s & Dementia. 9(4S_Part_7). 8 indexed citations
6.
7.
8.
Ross, Joel & Bruno P. Imbimbo. (2010). Are γ-secretase inhibitors detrimental for Alzheimer's disease patients?. Journal of Alzheimer s Disease. 22(2). 401–404. 6 indexed citations
9.
Imbimbo, Bruno P., E. Frigerio, Massimo Breda, et al.. (2010). P3‐411: Safety and pharmacokinetics of CHF5074, a novel gamma‐secretase modulator, after single oral administration to healthy humans. Alzheimer s & Dementia. 6(4S_Part_19). 1 indexed citations
10.
Raskind, Murray A., Earvin Liang, Reisa Sperling, et al.. (2009). P3‐246: Pharmacokinetics and pharmacodynamics of bapineuzumab following multiple intravenous infusions in patients with mild‐to‐moderate Alzheimer's disease. Alzheimer s & Dementia. 5(4S_Part_14). 2 indexed citations
11.
12.
Oertel, Wolfgang H., Joel Ross, Karla Eggert, & Georg Adler. (2007). Rationale for transdermal drug administration in Alzheimer disease. Neurology. 69(4_suppl_1). S4–9. 54 indexed citations
13.
Shua‐Haim, Joshua R., et al.. (2000). Donepezil (Aricept®) treatment of multi infarct dementia: The caregivers and clinical impression. 15(4). 201–211. 7 indexed citations
14.
Ross, Joel & Joshua R. Shua‐Haim. (2000). Geriatric photo quiz. Aneurysm. Cardiovascular problem can present in various locations and requires diligent management.. PubMed. 55(2). 31, 80–31, 80. 2 indexed citations
15.
Shua‐Haim, Joshua R., et al.. (1999). The “Co-pilot driveer syndrome:” A newly-reported driving habit in patients with Alzheimer's diseas. DigitalGeorgetown (Georgetown University Library). 14(2). 88–92. 4 indexed citations
16.
Shua‐Haim, Joshua R. & Joel Ross. (1999). Current and the near future medications for Alzheimer's disease: What can we expect from them?. 14(5). 294–307. 1 indexed citations
17.
Shua‐Haim, Joshua R. & Joel Ross. (1998). Alzheimer's Syndrome and not Alzheimer's disease: The historical struggle to define the disease. 13(2). 92–95. 2 indexed citations
18.
Shua‐Haim, Joshua R., et al.. (1997). Donepezil (AriceptTM): The caregivers voice and clinical impression. 12(6). 272–279. 7 indexed citations
19.
Ross, Joel, et al.. (1979). A practical alternative for the treatment of tantrum and self-injurious behavior. Journal of Behavior Therapy and Experimental Psychiatry. 10(1). 73–75. 7 indexed citations
20.
Talbott, John A., et al.. (1976). Flowering Plants as a Therapeutic/Environmental Agent in a Psychiatric Hospital1,2. HortScience. 11(4). 365–366. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shajan Koshy Breakdown of academic impact, for papers by Gül Özbey Breakdown of academic impact, for papers by William H. Cevallos Breakdown of academic impact, for papers by Viviana Noriega Breakdown of academic impact, for papers by Aikaterini Zisaki Breakdown of academic impact, for papers by Nina Gårevik Breakdown of academic impact, for papers by Ashley Selman Breakdown of academic impact, for papers by Renmin Yang Breakdown of academic impact, for papers by Paola Bisceglia Breakdown of academic impact, for papers by Özgür Gündüz
Rankless by CCL
2026